| 1 Tipton KF.Enzymology of monoamine oxidase.Cell Biochem Funct,1986,4:79-87.2 Dingemanse J,Zürcher G,Kettler R.Investigation of a correlation between monoamine oxidase B and catechol-O-methyltransferase activity in human blood cells.Eur J Pharm Sci,2000,12:159-163.3 Kalgutkar S,Dalvie DK,.Castagnoli JN,et al.Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors.Chem Res Toxicol,2001,14:1139-1162.4 Youdim MB,Finberg JPM.,Tipton KF.A comprehensive review of the biochemistry,physiology and pharmacology of monoamineoxidases up until 1988.Handb Exp Pharmacol (eds Trendelenburg,U.& Weiner,N.)127-199 (Springer,Berlin,1988).5 Shih JC,Chen K,Ridd MJ.A comprehensive review of the cloning of monoamine oxidases,and the physiological and behavioural effects of their knockout.Monoamine oxidase:from genes to behavior.Annu Rev Neurosci,1999,22:197-217 .6 Tipton KF,Boyce S,O’Sullivan J,et al.A comprehensive review of established and nonestablished aspects of MAOs and their inhibitors.Monoamine oxidases: certainties anduncertainties.Curr Med Chem,2004,11:1965-1982.7 Kalgutkar AS,Dalvie DK,Castagnoli N,et al.nteractions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors.Chem Res Toxicol,2001,14:1139-1162 .8 O’Carroll A.-M,Fowler CJ,Phillips JP,et al.The deamination of dopamine by human brain monoamine oxidase.Specificity for the two enzyme forms in seven brain regions.Naunyn Schmiedeberg’s Arch Pharmacol,1983,322:198-202.9 Binda FC,Hubálek ML,Edmondson DE,et al.Crystal structure of human monoamine oxidase B,a drug target enzyme monotopically inserted into the mitochondrial outer membrane.FEBS Lett,2004,564:225-228.10 Edmondson DE,Mattevi A,Binda C,et al.Structure and mechanism of monoamine oxidase.Curr Med Chem,2004,11:1983-1993.11 Wang H,Guo BH,Wu ZJ,et al.Screening of a Lactobacillus casei with monoamine oxidase-inhibitory activity.J Acta Microbiol Sin,2010,50(2):197-203.12 Stafford GI,Pedersen PD,Jager AK,et al.Monoamine oxidase inhibition by southern African traditional medicinal plants.S Afr J Bot,2007,73:384-39013 Holt DF,Sharman GB,Baker MM.A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates.Anal Biochem,1997,244: 384-392 .14 Weissbach H,Smith TE,Daly JW,et al.A rapid spectrophotometric assay of monoamine oxidase based on the rate of disappearance of kynuramine.J Biol Chem,1960,235:1160 .15 Schmidt K,Li Z,Schubert B,et al.Screening of entomopathogenic Deuteromycetes for activities on targets involved in degenerative diseases of the central nervous system.J Ethnopharmacol,2003,89:251-260 .16 Bembenek ME,Abell CW,Chrisey LA,et al.Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-,3,4-dihy-dro- and fully aromatic isoquinolines.J Med Chem,1990,33: 147-152.17 White HL,Scates P.Mechanism of monoamine oxidase-A inhibition by BW 1370U87.Drug Dev Res,1992,25:191-199.18 Mazouz F,Gueddari S,Burstein C,et al.R.5-(4-Benzyloxyphenyl)-1,3,4-oxadiazol-2(3H)-one derivatives and related analogues: new reversible,highly potent,and selective monoamine oxidase type B inhibitors.J Med Chem,1993,36: 1157-1167.19 Suzuki O,Katsumata Y,Oya M,et al.Hostettmann K.Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones.Planta Med,1981,42:17-21.20 Thull U,Testa B.Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases.Bio-chem Pharmacol,1994,47:2307-2310. |